US FDA approves AbbVie’s drug for Parkinson’s disease

Sept 25 (Reuters) – The US Food and Drug Administration has approved AbbVie’s drug for Parkinson’s disease in adults, the health regulator’s website showed on Friday.

(Reporting by Kamal Choudhury in Bengaluru; Editing by Shilpi Majumdar)

Brought to you by www.srnnews.com

Click here to read the full article